Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Theravance Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 19
» View wsbtradio.com items only
    May 24, 2013 |Story| Reuters
  1. Wall Street posts first weekly loss since mid-April on Fed angst

    NEW YORK (Reuters) - The S&P 500 declined for a third day on Friday, with the three major stock indexes posting their first negative week since mid-April on lingering concern that the central bank may scale back its stimulus measures to support the economy.
    Reuters
    NEW YORK (Reuters) - The S&P 500 declined for a third day on Friday, with the three major stock indexes posting their first negative week since mid-April on lingering concern that the central bank may scale back its stimulus measures to support the...

    Tags: Social Media, House Building, Upstream Oil and Gas Activities, AOL LLC, Pain Therapeutics

  2. May 23, 2013 |Story| Reuters
  3. Elan rejects Royalty's $6.4 billion raised offer

    Reuters
    DUBLIN (Reuters) - Elan rejected Royalty Pharma's increased $6.4 billion bid on Thursday, shortly after the U.S. firm cut the acceptance bar for its latest offer to 50 percent plus one share. Royalty raised its hostile cash bid to $12.50 per share on...

    Tags: Rheumatoid Arthritis, Elan Corporation Plc, Biogen Idec Incorporated, Humira (drug), GlaxoSmithKline PLC

  4. May 20, 2013 |Story| Reuters
  5. US high-yield issuers rush to market

    Reuters
    By Joy Ferguson and Rachelle Kakouris May 20 (IFR) - It's looking like another busy week for high-yield as issuers rush in ahead of the long Memorial Day weekend to take advantage of the current window for issuance at near-record low coupons. A total...

    Tags: Bonds, Deutsche Bank AG, Credit Ratings, Radiation Therapy, Prices

  6. May 20, 2013 |Story| Reuters
  7. Royalty Pharma ups offer for Elan to $12.50/shr

    Reuters
    LONDON, May 20 (Reuters) - U.S. investor Royalty Pharma raised its offer to $12.50 per share for Irish drugmaker Elan on Monday, representing a premium of 45 percent to Elan's enterprise value, it said. The company said it was offering $4.6 billion for...

    Tags: Elan Corporation Plc, Biogen Idec Incorporated

  8. May 20, 2013 |Story| Reuters
  9. Royalty raises Elan bid, issues ultimatum to shareholders

    Reuters
    DUBLIN/NEW YORK (Reuters) - Royalty Pharma raised its hostile bid for Elan to $12.50 per share and threatened to withdraw the bid if Elan shareholders approve a series of defensive transactions announced by the Irish drug firm. Royalty Pharma, which buys...

    Tags: Alzheimer's Disease, Stock Activities, Elan Corporation Plc, Buyback, Companies and Corporations

  10. May 20, 2013 |Story| Reuters
  11. Royalty eleva oferta por Elan, emite ultimátum a accionistas

    Reuters
    Por Padraic Halpin y Jessica Toonkel DUBLIN/NUEVA YORK, 20 mayo (Reuters) - Royalty Pharma elevó su oferta hostil por Elan a 12,50 dólares por acción y amenazó con retirar la oferta si los accionistas de Elan aprueban una serie de transacciones...

    Tags: Elan Corporation Plc, GlaxoSmithKline PLC

  12. May 15, 2013 |Story| Reuters
  13. Elan says Royalty wanted to take it private before Tysabri deal

    Reuters
    DUBLIN, May 15 (Reuters) - Royalty Pharma last year urged Elan to hold off on a multi-billion dollar drug deal until it had taken the Irish drugmaker private to boost the compensation the firms' executives would receive, Elan said on Wednesday. Royalty...

    Tags: Elan Corporation Plc, Shareholders, Companies and Corporations, Economy, Business and Finance, Biogen Idec Incorporated

  14. May 14, 2013 |Story| Reuters
  15. U.S. RESEARCH ROUNDUP: Yahoo, Microsoft, American Express, ArcelorMittal

    Reuters
    May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Yahoo and Microsoft, on Tuesday. HIGHLIGHTS * Yahoo : Goldman Sachs raises target to $30 from $27; rating conviction list buy...

    Tags: Best Buy Co., Inc., DiamondRock Hospitality Company, Comcast Corporation, Take-Two Interactive Software Inc., HSBC Holdings plc

  16. May 13, 2013 |Story| Reuters
  17. Ten new deals enter US high-yield pipeline

    Reuters
    By Rachelle Kakouris NEW YORK, May 13 (IFR) - The high-yield market started where it left off Friday with the new issue window remaining wide open for corporate borrowers across the credit spectrum. Ten new dollar deals entered the pipeline this...

    Tags: Neenah Paper Incorporated, Bonds, JPMorgan Chase & Co., House Building, Deutsche Bank AG

  18. May 13, 2013 |Story| Reuters
  19. Wall St termina plano tras recientes máximos

    Reuters
    Por Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...

    Tags: S&P 500, Nasdaq Composite, Elan Corporation Plc, Financial Markets, Stock Market

  20. May 13, 2013 |Story| Reuters
  21. U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group

    Reuters
    May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...

    Tags: DiamondRock Hospitality Company, Energy Partners Limited, Entertainment, Darling International Incorporated, Susquehanna Bancshares Incorporated

  22. May 13, 2013 |Story| Reuters
  23. Elan alcanza acuerdo por regalías de 1.000 mln dlrs con Theravance

    Reuters
    Por Padraic Halpin DUBLIN (Reuters) - Elan intensificó el lunes su intento por mantener su independencia al alcanzar un acuerdo de 1.000 millones de dólares para comprar el 21 por ciento de las regalías que la firma estadounidense Theravance recibe de...

    Tags: Elan Corporation Plc, Biogen Idec Incorporated, GlaxoSmithKline PLC

 1  2Next >
Original site for Theravance Incorporated topic gallery.